| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
75,030,000 |
| Market
Cap: |
4.29(B) |
| Last
Volume: |
1,047,320 |
Avg
Vol: |
401,055 |
| 52
Week Range: |
$45.92 - $86.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Specialized Health Services |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile RadNet is a provider of freestanding, fixed-site outpatient diagnostic imaging services. Co. operates directly or indirectly through joint ventures with hospitals, various centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Co.'s centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Co.'s services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy and other related procedures.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
143,399 |
188,399 |
254,256 |
551,202 |
| Total Sell Value |
$8,268,182 |
$10,538,622 |
$15,569,136 |
$33,375,299 |
| Total People Sold |
5 |
7 |
9 |
13 |
| Total Sell Transactions |
7 |
14 |
17 |
39 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sorensen Gregory |
EVP, Chief Science Officer |
• • – |
2025-06-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,600 |
1,165,345 |
|
- |
|
| Swartz David L |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,699 |
176,766 |
|
- |
|
| Jacobs Laura Pastre |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,699 |
27,007 |
|
- |
|
| Spurlock Gregory E. |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,699 |
5,290 |
|
- |
|
| Levitt Lawrence L |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,699 |
167,656 |
|
- |
|
| Murdock Michael N |
EVP, Mergers and Acquisitions |
• – – |
2025-06-05 |
4 |
S |
$58.05 |
$646,213 |
D/D |
(11,132) |
43,084 |
|
2% |
|
| Sorensen Gregory |
EVP, Chief Science Officer |
• • – |
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,436 |
1,170,945 |
|
- |
|
| Sorensen Gregory |
EVP, Chief Science Officer |
• • – |
2025-05-23 |
4 |
S |
$56.48 |
$3,106,400 |
D/D |
(55,000) |
1,160,509 |
|
-1% |
|
| Sorensen Gregory |
EVP, Chief Science Officer |
• • – |
2025-05-22 |
4 |
S |
$57.06 |
$2,567,700 |
D/D |
(45,000) |
1,215,509 |
|
-1% |
|
| Levitt Lawrence L |
Director |
– • – |
2025-05-16 |
4 |
S |
$61.09 |
$305,450 |
D/D |
(5,000) |
164,957 |
|
7% |
|
| Forthuber Stephen M |
Pres & COO-Eastern Operations |
• – – |
2025-05-16 |
4 |
S |
$60.34 |
$1,135,599 |
D/D |
(18,820) |
535,182 |
|
7% |
|
| Hames Norman R |
Pres and COO-West Operations |
• – – |
2025-05-15 |
4 |
S |
$60.00 |
$174,660 |
I/I |
(2,911) |
24,889 |
|
5% |
|
| Hames Norman R |
Pres and COO-West Operations |
• – – |
2025-05-15 |
4 |
S |
$60.00 |
$332,160 |
D/D |
(5,536) |
249,183 |
|
5% |
|
| Sorensen Gregory |
EVP, Chief Science Officer |
• • – |
2025-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,232 |
1,260,509 |
|
- |
|
| Patel Mital |
EVP of Fin Planning, CAO |
• – – |
2025-04-04 |
4 |
OE |
$6.30 |
$433,315 |
D/D |
50,340 |
230,138 |
|
- |
|
| Hames Norman R |
Pres and COO-West Operations |
• – – |
2025-03-19 |
4 |
S |
$50.13 |
$251,100 |
D/D |
(5,000) |
251,959 |
|
-13% |
|
| Hames Norman R |
Pres and COO-West Operations |
• – – |
2025-03-18 |
4 |
S |
$48.25 |
$241,250 |
D/D |
(5,000) |
256,959 |
|
-18% |
|
| Hames Norman R |
Pres and COO-West Operations |
• – – |
2025-03-17 |
4 |
S |
$49.79 |
$248,950 |
D/D |
(5,000) |
261,959 |
|
-17% |
|
| Katz David Jeffrey |
EVP and Chief Legal Officer |
• – – |
2025-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,423 |
103,774 |
|
- |
|
| Swartz David L |
Director |
– • – |
2025-03-07 |
4 |
S |
$50.84 |
$1,271,000 |
D/D |
(25,000) |
174,067 |
|
-14% |
|
| Wesdorp Cornelis |
Pres & CEO, Digital Health |
• – – |
2025-03-07 |
4 |
S |
$50.52 |
$50,520 |
D/D |
(1,000) |
55,995 |
|
-14% |
|
| Wesdorp Cornelis |
Pres & CEO, Digital Health |
• – – |
2025-03-06 |
4 |
S |
$51.23 |
$102,460 |
D/D |
(2,000) |
56,995 |
|
-11% |
|
| Wesdorp Cornelis |
Pres & CEO, Digital Health |
• – – |
2025-03-05 |
4 |
S |
$52.58 |
$105,160 |
D/D |
(2,000) |
58,995 |
|
-8% |
|
| Hames Norman R |
Pres and COO-West Operations |
• – – |
2025-03-05 |
4 |
OE |
$10.05 |
$120,828 |
D/D |
11,956 |
255,959 |
|
- |
|
| Berger Howard G |
President, CEO |
• • – |
2025-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
53,648 |
218,451 |
|
- |
|
427 Records found
|
|
Page 1 of 18 |
|
|
0.93 (1.6%) 
